Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

KIT Royal Tropical Institute, Amsterdam

Oct 19, 2022 6:30 PM - Oct 20, 2022 11:30 PM

Mauritskade 63, 1092 Amsterdam, Netherlands

Clinical Trials and Data Science Conference

Overview

The Future of Clinical Trials is Decentralised.

During the pandemic, decentralised clinical trials became more and more relevant. With moving away from on-site trials, this new trend changes the reality of big and complex data management, the use of artificial intelligence tools and new regulatory frameworks. How do we manage gathering, storage and processing of data in a decentralised environment? The community still discusses the full application of CTIS and the regulatory application.

At the Clinical Trials and Data Science Conference, decision-makers across the industry, regulatory and patient organisations will meet to discuss the future of clinical trials to find innovative solutions.

Key Topics

  • Decentralised Clinical Trials
  • Use of Data Science in Clinical Trials
  • Updates on the EMA/HMA Big Data Taskforce
  • DARWIN EU
  • Data Protection and Security
  • Artificial Intelligence Regulatory Frameworks: Impact on Pharma
  • IMI Initiatives
  • European Health Data Space (EHDS)
  • RWE

Why should you attend this conference?


Featured

Want to learn more about Clinical Trials and Data Science Conference? You've come to the right site!

Exhibits

Program Committee

  • Álmath  Spooner, PhD
    Álmath Spooner, PhD Head of Europe Regulatory Policy & Intelligence (RPI)
    Abbvie, Ireland
  • Daniel  Millar, MBA
    Daniel Millar, MBA Senior Director, Strategic Business Transformation
    Johnson & Johnson, United States
  • Elke  Stahl, PhD
    Elke Stahl, PhD Senior Expert, Clinical Trials Department
    Federal Institute For Drugs and Medical Devices (BfArM), Germany
  • Jesper  Kjær, MS
    Jesper Kjær, MS Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
    Novo Nordisk, Denmark
  • Patrick  Brady, PharmD
    Patrick Brady, PharmD Global Head, Therapeutic Innovation & Regulatory Science
    IQVIA, United States
  • Joyce  Swart
    Joyce Swart Director, Clinical Trial Disclosure
    Alcon Research, LLC, United States
  • Nick  Sykes, MS
    Nick Sykes, MS Policy Advisor, Regulatory Strategy
    EFPIA, Belgium
  • Ruediger  Pankow, DrSc
    Ruediger Pankow, DrSc Clinical Trial Regulatory Consultant | CTIS SME
    Independent Consultant, Germany
  • Fia  Westerholm, DVM, MSc
    Fia Westerholm, DVM, MSc Programme Assurance Manager
    European Medicines Agency, Netherlands

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.